Literature DB >> 27159262

Prevalence, Incidence, and Disease Characteristics of Takayasu Arteritis by Ethnic Background: Data From a Large, Population-Based Cohort Resident in Southern Norway.

Birgir Gudbrandsson1, Øyvind Molberg2, Torhild Garen3, Øyvind Palm3.   

Abstract

OBJECTIVE: To study the epidemiology and clinical characteristics of Takayasu arteritis (TAK) in southeast Norway (population 2.8 million).
METHODS: All study area hospital databases were screened to capture every potential TAK case between 1999 and 2012. These cases were manually chart reviewed, and only patients fulfilling either the 1990 American College of Rheumatology classification or the 1995 Ishikawa diagnostic criteria were included.
RESULTS: Inclusion criteria were met by 78 patients (68 female, 10 male). Point prevalence (by 2012) segregated by ethnic origin was 22.0 per 106 (95% confidence interval [95% CI] 17-29) in northern Europeans compared to 78.1 (95% CI 38-152) in Asian whites and 108.3 (95% CI 46-254) in Africans (P < 0.001). The incidence rate increased from 1 to 2 per 106 in the first to last 5-year period of the study (P = 0.03). Northern Europeans were mean age 32.3 years at onset, and 47% had involvement confined to aortic arch branches (angiographic type I), while 24% had extensive type V disease. Mean onset age in Asian and African cases was 20.3 years and 47% had type V disease. Coexisting inflammatory bowel disease was observed in 8% and ankylosing spondylitis in 7%.
CONCLUSION: We report 2-4 times higher population prevalence than previously observed, and the highest prevalence ever found in Norwegians of Asian and African descent. The results support the idea that TAK in northern Europeans is marked by limited arterial involvement and older age at onset.
© 2016, American College of Rheumatology.

Entities:  

Mesh:

Year:  2016        PMID: 27159262     DOI: 10.1002/acr.22931

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  18 in total

Review 1.  Sex Differences in Pediatric Rheumatology.

Authors:  Marco Cattalini; Martina Soliani; Maria Costanza Caparello; Rolando Cimaz
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

Review 2.  Takayasu Arteritis: Recent Developments.

Authors:  Maria L F Zaldivar Villon; Jose A Leon de la Rocha; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2019-07-18       Impact factor: 4.592

3.  Unlikely culprit: congenital middle aortic syndrome diagnosed in the sixth decade of life.

Authors:  Muhammad Sajawal Ali; Stefan Tchernodrinski; Divyanshu Mohananey; Ahya Sajawal Ali
Journal:  BMJ Case Rep       Date:  2016-08-16

Review 4.  Takayasu arteritis - epidemiology, pathogenesis, diagnosis and treatment.

Authors:  Dominika Podgorska; Rafal Podgorski; David Aebisher; Piotr Dabrowski
Journal:  J Appl Biomed       Date:  2019-01-09       Impact factor: 1.797

Review 5.  Large-vessel vasculitis.

Authors:  Dan Pugh; Maira Karabayas; Neil Basu; Maria C Cid; Ruchika Goel; Carl S Goodyear; Peter C Grayson; Stephen P McAdoo; Justin C Mason; Catherine Owen; Cornelia M Weyand; Taryn Youngstein; Neeraj Dhaun
Journal:  Nat Rev Dis Primers       Date:  2022-01-06       Impact factor: 65.038

Review 6.  Takayasu's arteritis occurring under TNF blockers in a patient with spondyloarthritis: is it an association or a paradoxical effect?

Authors:  Amel Rezgui; Maissa Thabet; Sahar Makki; Jihed Anoun; Imen Ben Hassine; Monia Karmeni; Fatma Ben Fredj; Anis Mzabi; Chedia Laouani
Journal:  Reumatologia       Date:  2021-02-09

Review 7.  Cutaneous Manifestations of Medium- and Large-Vessel Vasculitis.

Authors:  Francois Chasset; Camille Francès
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 10.817

8.  The clinical characteristics of Chinese Takayasu's arteritis patients: a retrospective study of 411 patients over 24 years.

Authors:  Jing Li; Fei Sun; Zhe Chen; Yunjiao Yang; Jiuliang Zhao; Mengtao Li; Xinping Tian; Xiaofeng Zeng
Journal:  Arthritis Res Ther       Date:  2017-05-25       Impact factor: 5.156

9.  TNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; an observational, population-based time trend study.

Authors:  Birgir Gudbrandsson; Øyvind Molberg; Øyvind Palm
Journal:  Arthritis Res Ther       Date:  2017-05-18       Impact factor: 5.156

10.  The combined prevalence of classified rare rheumatic diseases is almost double that of ankylosing spondylitis.

Authors:  Judith Leyens; Tim Th A Bender; Martin Mücke; Christiane Stieber; Dmitrij Kravchenko; Christian Dernbach; Matthias F Seidel
Journal:  Orphanet J Rare Dis       Date:  2021-07-22       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.